Cognizant, AstraZeneca in deal
2011-11-30Cognizant has signed a multi-year agreement with AstraZeneca to deliver comprehensive biostatistics and medical reporting services for generating clinical study reports. Financial details are not disclosed yet.Cognizant has claimed that the Company will render centralised statistical programming, statistical analysis, medical writing, and document publishing services across the entire chain of clinical data reporting from case report forms to clinical study reports under the agreement.
This is believed to enable AstraZeneca to increase operational efficiency, reduce cycle times, and optimise costs. AstraZeneca is said to continue to own and manage key scientific and medical activities associated with the design of clinical trial programmes, and the interpretation of data from them.The agreement is supposed to further expand the services that Cognizant provides to AstraZeneca.
See What’s Next in Tech With the Fast Forward Newsletter
Tweets From @varindiamag
Nothing to see here - yet
When they Tweet, their Tweets will show up here.